Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes

Date first appeared online	27/01/2022
DOI	10.1093/immadv/ltac002
Authors	Luzio S., Dunseath G., Holland G., Cheung I.
Journal Name	Immunotherapy Advances
Volume	2

Documents

• 61405_VoR.pdf , Book, © The Author(s) 2022. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License